Evidence map›Paper›PMID 37808991›Full record

Observational studyFrontiers in public health2023

Relationship between clinical-epidemiological parameters and outcomes of patients with COVID-19 admitted to the intensive care unit: a report from a Brazilian hospital.

Maisah Meyhr D'Carmo Sodré, Uener Ribeiro Dos Santos, Heitor Portella Povoas, Júlio Lenin Guzmán, Caroline Junqueira, Tayana Oliveira Trindade, Sandra Rocha Gadelha, Carla Cristina Romano, Aline Oliveira da Conceição, Eduardo Gross and 6 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Maisah Meyhr D'Carmo SodréDepartment of Biological Sciences, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Uener Ribeiro Dos SantosDepartment of Biological Sciences, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Heitor Portella PovoasHospital de Ilhéus, Ilhéus, Bahia, Brazil.
Júlio Lenin GuzmánHospital de Ilhéus, Ilhéus, Bahia, Brazil.
Caroline JunqueiraProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, United States.
Tayana Oliveira TrindadeHospital de Ilhéus, Ilhéus, Bahia, Brazil.
Sandra Rocha GadelhaDepartment of Biological Sciences, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Carla Cristina RomanoDepartment of Biological Sciences, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Aline Oliveira da ConceiçãoDepartment of Biological Sciences, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Eduardo GrossDepartment of Biological Sciences, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Aline SilvaDepartment of Biological Sciences, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Rachel Passos RezendeDepartment of Biological Sciences, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Renato FontanaDepartment of Biological Sciences, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Camila Pacheco Silveira Martins da MataLaboratory of Microbiology, Risoleta Tolentino Neves Hospital, Belo Horizonte, Minas Gerais, Brazil.
Lauro Juliano MarinDepartment of Health, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Luciana Debortoli de CarvalhoDepartment of Biological Sciences, Santa Cruz State University, Ilhéus, Bahia, Brazil.
Universidade Estadual de Santa Cruz · BRBoston Children's Hospital · USHospital Risoleta Tolentino Neves · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: People in low-income countries, especially those with low socio-economic conditions, are likelier to test positive for SARS-CoV-2. The unequal conditions of public health systems also increase the infection rate and make early identification and treatment of at-risk patients difficult. Here, we aimed to characterize the epidemiological profile of COVID-19 patients in intensive care and identify laboratory and clinical markers associated with death. Materials and methods: We conducted an observational, descriptive, and cross-sectional study in a reference hospital for COVID-19 treatment in the Southern Region of Bahia State, in Brazil, to evaluate the epidemiological, clinical, and laboratory characteristics of COVID-19 patients admitted to the intensive care unit (ICU). Additionally, we used the area under the curve (AUC) to classify survivors and non-survivors and a multivariate logistic regression analysis to assess factors associated with death. Data was collected from the hospital databases between April 2020 and July 2021. Results: The use of bladder catheters (OR 79.30; Conclusion: We suggest that multi-laboratory parameters can predict patient prognosis and guide healthcare teams toward more assertive clinical management, better resource allocation, and improved survival of COVID-19 patients admitted to the ICU.

Indexed as

COVID-19BrazilCOVID-19 Drug TreatmentCross-Sectional StudiesHospitalsHumansIntensive Care UnitsSARS-CoV-2biomarkerscatheterCOVID-19epidemiologyin-hospital mortalityintensive care unitSAPS3SARS-CoV-2

Identifiers

PMID37808991
PMCPMC10556466
OpenAlexW4386960945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.